The risk of herpes zoster in patients with ankylosing spondylitis: Analysis of the Korean National Health Insurance Service - Sample cohort database.
Doo-Ho LimYe-Jee KimSeon Ok KimSeokchan HongChang-Keun LeeBin YooYong-Gil KimPublished in: Modern rheumatology (2017)
Treatment with either TNFα inhibitors or cDMARDs is associated with a higher risk of HZ, especially in female patients and older patients, and these two patient groups could therefore benefit from HZ vaccination.
Keyphrases
- health insurance
- ankylosing spondylitis
- end stage renal disease
- rheumatoid arthritis
- newly diagnosed
- ejection fraction
- chronic kidney disease
- mental health
- healthcare
- disease activity
- peritoneal dialysis
- affordable care act
- prognostic factors
- case report
- quality improvement
- patient reported outcomes
- systemic lupus erythematosus
- adverse drug
- replacement therapy
- drug induced